HOME › DRUGS › LORLATINIB
ACTIVE SUBSTANCE / INN

LORLATINIB

Brand name(s): Lorviqua, LORBRENA
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA210868
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Lorlatinib
REGULATORS
FDA · EMA
SPONSORS / MAH
Pfizer Europe MA EEIG, PFIZER
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LORBRENANDA210868PFIZERPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LorviquaPfizer Europe MA EEIGAuthorised06/05/2019Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON LORLATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →